Abstract
A retrospective study was performed on the clinical outcome and long-term treatment of 17 patients with propionic acidaemia diagnosed during the last 20 years in our hospital. The study group consisted of 12 patients with early onset type of disease and 5 patients with late onset. Seven (41%) patients died, five with early onset and two with late onset. The deceased early onset patients had a median survival of 0.4 years while the deceased late onset patients died at the age of 2.8 and 4 years respectively. Median age of the living early onset patients was 5.2 (1–9.25) years, the late onset patients were 4,7 and 23 years old. Patients were all treated with natural protein restriction and in most cases carnitine and metronidazole were added. The early onset patients were almost all treated with daily home tube feeding. The mean natural protein intake of early onset patients (6.3±1.5 g/day) was significantly lower than the natural protein intake of late onset patients (17.6±5.3 g/day). Supplemental protein intake was higher in early onset patients. The general neurological outcome of our study group was satisfactory with a better outcome for early onset patients. As to growth, many patients showed a failure to thrive, this was particularly for height. The strong protein restriction during the first years of life probably contributed to this.
Conclusion
The prognosis for patients with propionic acidaemia appeared to be satisfactory in terms of survival and outcome characteristics such as neurological and mental development. Despite these results the authors feel that the prognosis and quality of life of these patients might be improved with liver transplantation or possibly somatic gene therapy in the future.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- MMA :
-
methylmalonic acidaemia
- PA :
-
propionic acidaemia
- PCC :
-
propionyl CoA carboxylase
- SDS :
-
standard deviation score
References
Ando T, Rasmusen K, Nyhan WL, Donnell GN, Barnes ND (1971) Propionic acidemia in patients with ketotic hyperglycinemia. J Pediatr 78:827–832
Brunet Lézine O (1951) Le développement psychologique de la première enfance. Presse Universitaire Française, Paris
Childs B, Nyhan WL, Borden MA, Bard L, Cooke RE (1961) Idiopathic hyperglycinemia and hyperglycinuria, a new disorder of amino acid metabolism. Pediatrics 27:522–538
Fomon SJ (1991) Requirements and recommended dietary intakes of protein during infancy. Pediatric Res 30:391–395
Gompertz D, Storrs CN, Bau DC, Peters TJ, Hughes EA (1970) Localisation of enzymic defect in propionic acidemia. Lancet I:1140–1143
Hommes FA, Kuipers JRG, Elema JD, Jansen JF, Jonxis JHP (1968) Propionicacidemia, a new inborn error of metabolism. Pediatr Res 2:519–524
Hsia YE, Scully KJ, Rosenberg LE (1969) Defective propionate carboxylation in ketotic hyperglycinemia. Lancet 1:757–758
Hsia YE, Scully J, Rosenberg LE (1971) Inherited propionyl-CoA carboxylase deficiency in “ketotic hyperglycinemia”. J Clin Invest 50:127–130
Lehnert W, Sperl W, Suormala T, Baumgartner ER (1994) Propionic acidemia: clinical, biochemical and therapeutic aspects. Experience in 30 patients. Eur J Pediatr 153 (Suppl 1):S68-S80
Masoud AF, Leonard JV (1993) Cardiomyopathy in propionic acidemia. Eur J Pediatr 152:441–445
Müller S, Falkenberg N, Mönch E, Jakobs C (1980) Propionic acidemia and immunodeficiency. Lancet I:551–552
Ogier H, Charpentier C, Saudubray JM (1990) Organic acidemias. In: Fernandez J, Saudubray JM, Tada K (eds) Inborn metabolic diseases, diagnosis and treatment. Springer-Verlag, Berlin Heidelberg New York, pp 271–301
Roe CR, Hoppel CL, Stacey TE, Chalmers RA, Tracey BM Millington DS (1983) Metabolic response to carnitine in methylmalonic aciduria. An effective strategy for elimination of propionyl groups. Arch Dis Child 58:916–920
Sbaï D, Narcy C, Thompson GN, Mariotti A, Poggi F, Saudubray JM, Bresson JL Contribution of odd-chain fatty acid oxidation to propionate production in disorders of propionate metabolism. Am J Clin Nutr (in press)
Stankovics J, Ledley FD (1993) Cloning of functional alpha propionyl carboxylase and correction of enzyme deficiency in pccA fibroblasts. Am J Hum Genet 52:144–151
Surtees RAH, Matthews EE, Leonard JV (1992) Neurologic outcome of propionic acidemia. Pediatr Neurol 5:334–337
Sweetman L, Nyhan WL, Cravens J, Zomer JCY, Plunket DC (1979) Propionic acidemia presenting with pancytopenia in infancy. J Inherited Metab Dis 2:65
Van der Meer SB, Poggi F, Spada M, Saudubray JM, et al (1994) Clinical outcome of long-term management of 26 patients with vitamin B12-unresponsive methylmalonic acidemia. J Pediatr 125:903–908
Walter JH, Thompson GN, Leonard JV, Bartlett K, Halliday K (1989) Contribution of aminoacid catabolism to propionate production in methylmalonic acidemia. Lancet I:1298–1299
Wendel U (1989) Abnormality of odd-numbered long-chain fatty acids in erythrocyte membrane lipids from patients with disorders of propionate metabolism. Pediatr Res 25:147–150
Wolf B, Hsia YE, Sweetman L, Gravel R, Harris DJ, Nyhan WL (1981) Popionic acidemia: a clinical update. J Pediatr 99:835–846
Zazzo R, Gilly M, Verba M (1979) Nouvelle échelle métrique de l'intelligence. Collin-Bourrelier, Paris
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van der Meer, S.B., Poggi, F., Spada, M. et al. Clinical outcome and long-term management of 17 patients with propionic acidaemia. Eur J Pediatr 155, 205–210 (1996). https://doi.org/10.1007/BF01953939
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01953939